Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mesut BAYRAKTAROGLU"'
Autor:
Esra Yazar, Mesut Bayraktaroglu
Publikováno v:
Güncel Göğüs Hastalıkları Serisi. 8:50-54
Publikováno v:
Medeniyet medical journal. 37(2)
In this study, we aimed to investigate the compatibility of modified Medical Research Council (mMRC) and COPD assessment test (CAT) scores of chronic obstructive pulmonary disease (COPD) patients in terms of evaluation of their symptom status.The stu
Autor:
Sinem Iliaz, Gulshan Yunisova, Ozgur Oztop Cakmak, Ozlem Celebi, Eser Bulus, Arda Duman, Mesut Bayraktaroglu, Piraye Oflazer
Publikováno v:
Respiratory medicine. 200
The patients with neuromuscular diseases (NMD) are very fragile and it is hard to evaluate respiratory involvement of the primary disease in this group. Therefore, our study aimed to reveal the relationship between pulmonary function tests (PFT) and
Background: COVID-19 has become a pandemic and threatened human public health across the world. Determining effective predictive biomarkers that can classify patients according to risk levels is critical to identify cases that can potentially progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f03721d117aeaf3a28b796e7b760d0f
https://hdl.handle.net/20.500.12511/10237
https://hdl.handle.net/20.500.12511/10237
Publikováno v:
Current Medical Research and Opinion. 35:2187-2196
Objectives: The bronchodilator efficacy of a once-daily fixed-dose combination of tiotropium/formoterol (18/12 µg administered via a dry-powder inhaler, Discair) [TIO/FORMfixed group] vs a single-d...
Publikováno v:
Current medical research and opinion. 36(6)
Dear Editor,We are writing in response to the letter to the Editor regarding our clinical trial published in Current Medical Research and Opinion, entitled “Bronchodilator efficacy of tiotropium/fo...
Publikováno v:
Clinical Problems.
Gastric carcinoma and metastatic prostate carcinoma have rarely been reported as the cause of bilateral chylothorax. Although chylothorax is a potentially life threatening disease, successful results can be achieved with the urgent and optimal pallia
Publikováno v:
Clinical drug investigation. 39(10)
A patient-friendly and easy-to-use multi-dose dry powder inhaler, DiscairA total of 33 male patients with moderate-to-severe, chronic obstructive pulmonary disease were included in this single-arm, open-label, phase IV trial. The primary efficacy par
YUKSEL, KIVANC/0000-0003-3491-0099; Yildiz, Birsen Pinar/0000-0002-6650-1495; Bayraktaroglu, Mesut/0000-0002-9063-1118
WOS: 000487922800009
PubMed: 31332649
Background and Objectives: A patient-friendly and easy-to-use multi-dose dry p
WOS: 000487922800009
PubMed: 31332649
Background and Objectives: A patient-friendly and easy-to-use multi-dose dry p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0515f8a8965c46b12974d02969f8645c
https://hdl.handle.net/11454/63388
https://hdl.handle.net/11454/63388
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 11:2859-2867
PURPOSE To compare the bronchodilator efficacy of 18 μg once-daily tiotropium inhalation administered via Discair® versus HandiHaler® in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS Fifty-eight